RPB 2014 Stein Innovation Awardee David Williams, PhD, University of Rochester, who helped revolutionize the field of physiological optics through his use of adaptive optics, proposes to image retinal blood flow at the cellular level in diabetic patients. This technology has potential to detect diabetic retinopathy in its earliest stages, allowing for earlier clinical interventions and reducing the impact of this blinding disease.
Research to Prevent Blindness (RPB) recently awarded 36 grants totaling $4.8 million during its spring grant cycle. RPB will award additional grants in December.
The latest RPB awards include unrestricted grants to departments of ophthalmology at 21 medical schools across the U.S. and 14 awards to individual scientists. A special grant was awarded to the Association of University Professors of Ophthalmology for the development of vision research scientists and leaders. RPB currently supports eye research at 49 medical institutions throughout the United States.
Since it was founded in 1960, RPB has channeled more than $331 million into eye research. As a result, RPB has been identified with nearly every major breakthrough in vision research in that time.
July 23, 2015
CDA founded 30 years ago as one of the few private sources of funding aimed specifically at early-career vision researchers.
Vision scientists who have received RPB funding will help lead all five research teams, which will seek to accelerate development of regenerative treatments for blindness.
Research to Prevent Blindness (RPB) and Lions Clubs International Foundation (LCIF) announced today that they will continue their partnership in the RPB/LCIF Low Vision Research Award.
Award recipients to use IRIS Registry database to conduct population-based studies.
Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.
Partnership to utilize IRIS Registry database to advance patient care.
Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.
General Info | Grants | News & Resources |